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A B S T R A C T
Forensic DNA phenotyping is gaining interest as the number of applications increases within the forensic ge-
netics community. The possibility of providing investigative leads in addition to conventional DNA profiling for
human identification provides new insights into otherwise “cold” police investigations. The ability of reporting
on the bio-geographical ancestry (BGA), appearance characteristics and age based on DNA obtained from a crime
scene sample of an unknown donor makes the exploration of such markers and the development of new methods
meaningful for criminal investigations. The VISible Attributes through GEnomics (VISAGE) Consortium aims to
disseminate and broaden the use of predictive markers and develop fully optimized and validated prototypes for
forensic casework implementation. Here, the first VISAGE appearance and ancestry tool development, perfor-
mance and validation is reported. A total of 153 SNPs (96.84 % assay conversion rate) were successfully in-
corporated into a single multiplex reaction using the AmpliSeq™ design pipeline, and applied for massively
parallel sequencing with the Ion S5 platform. A collaborative effort involving six VISAGE laboratory partners
was devised to perform all validation tests. An extensive validation plan was carefully organized to explore the
assay’s overall performance with optimum and low-input samples, as well as with challenging and casework
mock samples. In addition, forensic validation studies such as concordance and mixture tests recurring to the
Coriell sample set with known genotypes were performed. Finally, inhibitor tolerance and specificity were also
evaluated. Results showed a robust, highly sensitive assay with good overall concordance between laboratories.
1. Introduction
The primary focus of forensic genetics research is the development
of new markers and techniques that allow for human individual iden-
tification. However, the applications of comparative approaches such as
standard forensic STR profiling are limited in cases without suspects
and/or national DNA database matches. This has prompted the forensic
genetics community to start the development of tools to infer in-
formation about the donor of biological traces found at the crime-scene
to be used in police investigations to help find unknown perpetrators of
crime. These investigative DNA analyses have been termed Forensic
DNA Phenotyping (FDP), which includes three components: the in-
ference of bio-geographical ancestry (BGA), the prediction of externally
visible characteristics (EVC), and the estimation of chronological age.
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FDP can serve as biological witness in cases without human eye-
witnesses, and also for the corroboration of eyewitness testimonies [1].
FDP is suitable for current and previous unsolved cases (cold cases)
without STR profile matches [2–4]. Other applications of FDP are
missing person and disaster victim identification (DVI) cases to provide
information in order to locate relatives or ante mortem samples. In all
these applications, FDP can help the police by narrowing down the
typically long list of putative suspects, relatives of victims, or victims.
Earlier FDP tools relied on conventional genotyping technologies
deemed suitable for forensic DNA analysis, e.g. SNaPshot-based min-
isequencing, which, however, are limited in the number of DNA mar-
kers that can be simultaneously analyzed [5–19]. More recent studies
have started to apply targeted massively parallel sequencing (MPS)
technologies for FDP tool developments, typically separating EVCs from
BGA [20–27]. Among those, three commercial kits are available i.e. i)
the Precision ID Ancestry Panel (Thermo Fisher Scientific, [23]) for
BGA, ii) the Ion Ampliseq™ DNA Phenotyping Panel (Thermo Fisher
Scientific) for hair and skin color prediction based on [14] and iii) the
ForenSeq DNA Signature Prep Kit (Verogen, [22]) for EVCs and BGA
(plus DNA markers for other purposes). The Precision ID Ancestry Panel
[23] comprises 165 BGA markers described in previous studies [28,29].
The ForenSeq™ DNA Signature Prep Kit [22], particularly its DNA
Primer Mix B, tests 56 BGA markers from a previous study [29] and 24
SNPs for eye and hair color (of which 2 markers overlap) from previous
studies [11,12]. Recently, a non-commercial MPS application of the
HIrisPlex-S SNP panel for simultaneous prediction of eye, hair and skin
color was published [25] for both the AmpliSeq-based Ion S5 System
(Thermo Fisher Scientific) as well as the MiSeq FGx (Illumina) MPS
platforms. Furthermore, other non-commercial SNP panels have been
recently developed for BGA inference using targeted MPS, such as the
EUROFORGEN Global AIMs SNP set with 128 BGA markers [21] and
more recently, the MAPlex panel with 144 BGA SNPs and 20 BGA mi-
crohaplotypes [24].
In this context, the VISible Attributes through GEnomics (VISAGE)
Consortium was created in 2017 to develop and validate new MPS-
based prototype tools for predicting BGA, appearance and age of an
unknown crime scene sample donor from evidence DNA, among other
project goals (http://www.visage-h2020.eu/). Here, the development
and the validation of the VISAGE Basic Tool for Appearance and
Ancestry prediction from DNA (herein BT A&A) is described for its
AmpliSeq-based version (herein BT A&A (Amp)), representing the first
FDP lab tool that combines DNA analysis of eye, hair, and skin color
with continental bio-geographic ancestry in a single assay.
2. Materials and methods
2.1. DNA markers
Selection of DNA markers for the BT A&A focused on previously
established knowledge. For appearance, this concerned eye, hair and
skin color as previously established appearance traits predictable from
DNA, and we employed the 41 DNA markers included in the previously
described IrisPlex [11], HIrisPlex [14] and HIrisPlex-S [30] test sys-
tems. For BGA, the most ancestry-informative markers (AIM-SNPs)
were taken from the previously developed EUROFORGEN Global AIMs
MPS ancestry panel [21,31], supplemented with two additional AIM-
SNPs from the 55 AIMs panel of Kiddlab (rs10497191, rs6990312,
[29]). Furthermore, eleven additional AIM-SNPs included in the
Thermo Fisher Precision ID ancestry panel (rs12130799, rs12629908,
rs1834619, rs2269793, rs3737576, rs459920, rs4781011, rs4918664,
rs705308, rs7226659, rs870347) were added. At the time of AIM-SNP
selection these had just become established for forensic ancestry ana-
lysis with the Ion S5 (please note that TFS Precision ID ancestry panel
also includes all 55 SNPs of the Kiddlab panel [29]). In addition to
continental population comparisons, the differentiation of the sub-
continental population groups in Eurasia of Middle East and South Asia
was an important target for the Basic Tool. The most informative
Middle East AIM-SNPs were chosen from the EUROFORGEN NAME
panel [27] and the most informative South Asian AIM-SNPs from the
original candidate SNPs compiled for the Eurasiaplex forensic ancestry
panel [32–34]. Lastly, 20 candidate tri-allelic SNPs with ancestry-in-
formative allele frequency distributions were targeted to provide scope
for mixed DNA detection – identified by the potential presence of three
alleles in the sequence data of these SNPs from multiple contributors.
The final AIM-SNP proportions in the developed BT A&A tool com-
prised: 56 AIM-SNPs from the Global AIMs panel with well-balanced
and powerful five group differentiation; 12 AIM-SNPs selected for
Middle East; 19 AIM-SNPs selected for South Asia; 2 + 11 additional
AIM-SNPs from the Thermo Fisher Precision ID ancestry panel; and 15
tri-allelic AIM-SNPs. Three pigmentation predictive SNPs: rs16891982,
rs1426654, rs12913832 are also standard BGA markers and were used
in the BT A&A for both purposes; leading to a total of 115 BGA markers,
of which 3 were already part of the EVC panel and 15 were tri-allelic
loci. Considering BGA and appearance DNA markers together, 153 DNA
markers (Supplementary Table S1, Supplementary Figure S1) were used
for the design of the BT A&A. Even though no formal linkage evaluation
was performed for the AIM markers, a rule of 1Mb minimum separation
between syntenic SNP pairs was applied for marker selection (except for
one transgression between SNPs rs12629908 and rs12498138 of 0.94
Mb).
2.2. Assay development, protocol and data analysis
For the currently described AmpliSeq-based version of the BT A&A,
the Ion AmpliSeq Designer algorithm (https://ampliseq.com/, Thermo
Fisher Scientific, Waltham, Massachusetts, USA, herein TFS) was used
to design and manufacture a single primer pool containing all DNA
markers for appearance and ancestry inference. The Ion AmpliSeq de-
signer algorithm has proven effective with other similar-sized panels for
human identification, ancestry prediction and even for full mitochon-
drial DNA sequencing [20,21,35]. Furthermore, the size of the ampli-
cons can be selected considering the application in downstream ana-
lysis.
All libraries were prepared automatically using the Precision ID DL8
Kit (TFS) and Ion Code barcodes on the Ion Chef System (TFS) following
the manufacturer’s protocols [36]. All produced pools (each batch of
eight libraries produces one pool) were quantified using the Ion Library
Quantitation Kit (TFS), and then two pools (16 libraries in total) were
combined once again equimolarly at 30 pM, when possible (or un-
diluted when not reaching a concentration of 30 pM). All final library
pools were loaded onto the Ion Chef System for template preparation
using the Ion S5 Precision ID Chef & Sequencing Kit (TFS) and loaded
automatically onto Ion 530 Chips (TFS). Finally, sequencing was per-
formed using the Ion S5 System (TFS, herein Ion S5), 16 libraries (2 DL8
batches) per Ion 530 Chip.
Raw data were processed using the S5 Torrent Server applying
Torrent Suite software V.5.6.0 (TFS). A TMAP alignment against the
hg19 genome assembly was performed. All BAM and BAI files produced
from the sequencing were manually inspected using Integrative
Genome Viewer (IGV) [51]. Genotypes were called with the plugin
HID_SNP_Genotyper V.5.2.2 (herein, SNP Genotyper) using default
parameters. All statistical analyses were performed using Microsoft
Excel and R (https://www.r-project.org/, [37,38]).
2.3. Validation
A comprehensive validation plan was designed for assessing the
overall performance of the BT A&A (Amp) assay. The plan comprised of
common developmental tests, including reproducibility, sensitivity,
mixtures and specificity, as well as challenging samples, such as mock
casework samples and artificially degraded DNA controls, and inhibitor
tolerance tests. The validation testing was shared among several
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VISAGE Consortium partners to perform all tests needed for the vali-
dation of the BT A&A (Amp) assay. In total, 18 of the 530 chips in nine
Ion S5 initializations were run in six VISAGE partner laboratories.
2.3.1. Reproducibility, sensitivity and altered PCR protocol
Reproducibility of the BT A&A (Amp) assay was assessed by pre-
paring three replicates of 2800 M control DNA (Promega, Madison, WI,
USA) at three different optimum inputs of 1, 2 and 10 ng in five dif-
ferent VISAGE laboratories (a total of 15 replicates per input were used
for analysis). The sequencing results allowed not only to analyze the
accuracy and precision of the method, but also to explore read depth
distribution, strand bias and rates of misincorporation. Furthermore,
typing DNA replicates under optimal conditions allowed the identifi-
cation and description of poorly performing SNPs.
A sensitivity dilution series from 1 ng to 0.01 ng input (1, 0.5, 0.25,
0.1, 0.05, 0.025, 0.01 ng) of 2800 M control DNA (Promega) was
prepared in duplicate and analyzed to identify the sensitivity threshold
of the assay and describe the genotype variations or inconsistences
occurring at low DNA inputs. Five different VISAGE laboratories per-
formed the same sequencing run, thus in total, ten replicates of each
dilution step were included in the analysis. In addition, an increased
cycle number PCR protocol (normal protocol - 22 cycles; modified
protocol - 27 cycles) was tested using the same dilution series. The
manufacturer (TFS) suggests such increased cycle protocols, particu-
larly when preparing challenging or low-level DNA samples (< 1 ng).
This experiment was repeated by three different laboratories; therefore,
three replicates per dilution step were used for the final analysis.
2.3.2. Concordance and mixtures
Six Coriell samples (NA07029, NA07000, NA06994, NA11200,
NA10540 and NA18498) were analyzed with the BT A&A (Amp) assay
for concordance analysis. The concordance tests were analyzed taking
into account: a) the known and accessible genotypes of the Coriell
samples in the 1000 Genomes Phase III data [39] and Simons Foun-
dation Genome Diversity Project (SGDP) [40] databases; and b) the
concordance between genotypes obtained from three distinct VISAGE
Consortium laboratories. Discordances with the 1000 Genomes Phase
III data were further inspected with the 1000 Genomes Project New
York Genome Center high coverage dataset.
Mixture identification and deconvolution is usually not described as
a goal for EVC and BGA typing methods, as these typically follow STR
analysis in a routine workflow. Hence, the STR results would indicate
the presence of a single source sample, which is preferred for EVC and
BGA analysis. Only under rare scenarios is it possible to derive EVC and
BGA information reliably from mixed DNA samples. However, for the
sake of completeness and because mixture detection in SNP panels, and
particularly in EVC and BGA panels, has been previously described and
published [20,21,25,41], this study was included in the validation. It is
based on the fluctuation of allele frequencies and increase of hetero-
zygosity values that indicate the presence of additional contributors.
Two Coriell samples with different biogeographical ancestries were
chosen to produce mixed profiles, in order to increase the probability of
detecting different alleles. Coriell samples NA18498 (African) and
NA07000 (European) were mixed in ratios 1:1, 1:3 and 1:9 at 1 ng final
input, prepared and sequenced in duplicate.
2.3.3. Challenging samples
Seven GEDNAP (German DNA Profiling Group, https://www.
gednap.org) proficiency testing samples, prepared from different bio-
logical tissues (two blood samples, two saliva samples, two semen
samples and one sample of unidentified origin) were chosen to test the
assay’s performance with mock casework samples. A batch of seven
traces was sent to each of five participating laboratories, who applied
their in-house extraction and quantification methods before analyzing
them with the BT A&A (Amp) assay. Furthermore, in order to evaluate
the assay’s ability to process degraded/fragmented samples, artificially
degraded samples were prepared and sequenced in two different
VISAGE laboratories. A sonication time series (0−360 min) of 007
control DNA was prepared using an ultra-sound cleaner at 40 kHz. All
samples were checked for increasing degradation by routine STR typing
using the PowerPlex ESI 17 typing kit (Promega). STRs were analyzed
on an ABI 3500 XL capillary electrophoresis instrument (Supplementary
Fig. S2). All challenging samples were prepared at 1 ng input when
possible, or at the highest DNA input possible.
2.3.4. Inhibitor tolerance
MPS tolerance to inhibitors has previously been shown to be lower
than common STR/capillary electrophoresis methods [42], with the
initial PCR being described as the critical point for failed genotype
sequencing. In order to further explore and describe the tolerance
thresholds of the Precision ID DL8 library preparation, three known
PCR inhibitors at varying concentrations (hematin, humic acid and
indigo carmine) were spiked into a 2800 M control DNA at 1 ng. As the
library preparation protocol used was fully automated, the final con-
centration of the inhibitors could not be exactly determined, therefore,
inhibitor levels are described considering the total amount used. He-
matin was tested at 8 × 10−4 - 2.5 × 10-5 μmol, humic acid at 1600 –
50 ng and indigo carmine dye at 0.16 – 0.005 μmol. All inhibitor-spiked
samples were prepared in two VISAGE laboratories, so two replicates of
each inhibitor concentration were included for analysis.
2.3.5. Species specificity
Fourteen animal DNA samples from different species
(Supplementary Table S2) were prepared at 1 ng input and sequenced
with the BT A&A (Amp) assay. Samples were selected considering either
their relevance in forensic casework analysis, such as domestic animals,
or their genetic similarity to human DNA testing primates.
3. Results and discussion
3.1. Assay design and development
Of the 158 EVC and BGA markers initially considered in the design,
primers for 153 markers were successfully included into one single,
functional multiplex assay using the AmpliSeq design algorithm (TFS).
With the purpose of designing an assay for forensic casework, which
can involve highly degraded samples, an assay containing the shortest
amplicons possible (around 175 bp) was designed. Five tri-allelic BGA
candidate markers as well as a single Middle East informative SNP were
rejected by the assay design process; representing an MPS assay con-
version rate for BGA-SNPs of 95 % (i.e. 116/121 candidates successfully
incorporated). All of the appearance informative markers were suc-
cessfully designed and incorporated into the final assay, thus reaching a
100 % MPS conversion rate for EVC-SNPs.
The BT A&A (Amp) assay was designed and firstly tested with op-
timum DNA input samples and a sensitivity dilution series to assess its
general performance by the Institute of Legal Medicine, Medical
University Innsbruck (MUI), before being distributed to five additional
VISAGE partner laboratories for further validation testing. No addi-
tional optimization of the PCR and library preparation steps was needed
by using the fully automated process.
All data processed by the VISAGE partner laboratories were sent to
MUI for uniform analysis and validation of the Basic Tool. Overall, 288
DNA samples were sequenced and analyzed during the validation pro-
cess, successfully completing all the tasks. Here, a compiled analysis of
the entire dataset is described.
3.2. Assay characterization and sequence quality
3.2.1. Coverage
In terms of total coverage, all replicates of optimum DNA input
reached values above 500,000 reads, with mean coverage values of
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1,077,374±354,052.51, 893,355±174,788.26 and 1,137,734±
366,024.97 for 1, 2 and 10 ng, respectively. Considering the total capacity
of a 530 chip is 15–20 million reads, when dividing by 16 samples the
optimum total number of reads per sample should vary between 937,500
to 1,250,000 reads. Both 1 ng and 10 ng mean total coverage values fall
within the expected interval, whereas the 2 ng mean value underperforms.
A statistical t-test was performed considering the total coverage obtained
from 1, 2 and 10 ng samples, respectively, resulting in a significant dif-
ference only when comparing the 2 ng replicates. However, such results
might stem from an artificial bias of the running scheme adopted for the
reproducibility samples. In fact, the mean total coverage of the 2 ng re-
plicates is the lowest of the three optimum inputs, but because these re-
plicates were always run simultaneously with the 10 ng replicates, the
latter ones might have outcompeted the 2 ng samples. A more detailed
analysis of normalized read depth – the read depth per marker divided by
the total number of reads (total coverage) – allows exploration of the
distribution of reads across the whole assay and pinpoints markers that are
under- or over-performing. The comparison between mean normalized
read depth distribution of 1 ng replicates against 2 ng and 10 ng, allows an
understanding of how the read distribution among markers differed with
DNA input. In addition to a formal Kolmogorov-Smirnov statistical test, a
consistent trend in marker behavior becomes evident with varying DNA
input amounts, as shown in Fig. 1, which clearly indicates that the BT A&A
(Amp) assay is not affected by variation in the optimum DNA input. When
considering all reads divided equally among the 153 SNPs, normalized
read depth per marker should be ∼0.0065 (represented as dashed lines in
Fig. 1A). The analysis of the mean normalized read depth per marker for
the 1, 2 and 10 ng replicates presented very similar results, showing 65.4
%, 63.4 % and 61.4 % of the markers above 0.006, respectively. Fur-
thermore, only 25–26 % of component SNPs showed a mean normalized
read depth below the first quartile (0.0046 – 0.0049). High mean read
depth per marker was obtained for 1 ng replicates (7,041.66±3,753.98
reads per SNP), all SNPs presenting more than 1000x average coverage,
which is above any threshold normally applied to forensic MPS. In fact, the
observed mean number of reads per SNP falls within the expected interval
of 6,127.45−8,169.93, obtained when dividing the expected optimum
total number of reads per sample by the number of markers (considering
16 samples per 530 Ion Chip). In addition, all genotypes compared be-
tween the five participating VISAGE laboratories were fully concordant for
the 1, 2 and 10 ng 2800 M replicates.
3.2.2. Strand bias
Strand bias was calculated as the ratio between reads covering the
forward strand and total reads (forward + reverse) at a specific target
site. Previous studies have indicated that bias in strand sequencing
might lead to less confident genotype calls, with a tendency for Ion
Torrent chemistry to present reverse strand sequencing preference [20].
Analysis of the 1 ng replicate mean results indicated only 20.55 % of the
target sites showed a strand bias ratio outside of the optimum interval
of 0.45< sb<0.55 (Supplementary Fig. S3A). Furthermore, a more
balanced distribution in preference for forward and reverse reads was
observed with 9.15 % of markers above 0.55 and 5.23 % below 0.45 on
average for 1 ng replicates.
3.2.3. Base misincorporation rates
The base misincorporation rate is commonly defined as the in-
corporation of an erroneous base at a SNP target site. This variation
across different targets is important to describe the precision of the
assay as well as to identify specific positions where a sequencing error is
observed at a higher than expected frequency. Due to its putative im-
pact on genotype calls, there is the necessity to distinguish between the
incorporation of a base that creates an alternative allele in a homo-
zygous genotype (or tri-allelic SNP) and the incorporation of a non-
specific base for the site. Supplementary Fig. S3B depicts the variation
of misincorporation rates divided into the two variants across the entire
assay. Furthermore, minimum allele read frequency thresholds can be
adapted to values that benefit the finding of minor contributors without
compromising the occurrence of dropins. The observed mean total
misincorporation rate was 0.23 %, 31 SNPs showed a total mis-
incorporation rate above the mean and only three SNPs presented a rate
above 1% (rs2789823, rs1040934 and rs7084970; all BGA markers,
Supplementary Table S3). For these SNPs a manual inspection of the
reads should be performed in order to identify misaligned reads and
prevent erroneous detection of minor alleles (Supplementary Table S3
and Supplementary File S1 for further details). Particularly, rs2789823
and rs7084970 are located in repetitive regions (GAGGG/ACCC and
TTAAAAC/TGAAT, respectively), therefore the erroneous incorporation
of cytosines in the reverse strands at rs2789823 and adenines in the
forward strands at rs7084970 can occur frequently and affect genotype
call (Supplementary File S1A-B). Such results are in concordance with
previous studies with AmpliSeq chemistry [20,21,43] A t-test was ap-
plied to examine whether there was a difference in the frequencies of
detecting an erroneous non-specific base or an erroneous base creating
Fig. 1. A) Mean normalized sequence read depth distribution of 1 ng replicates against 2 ng replicates (black dots), 1 ng versus 10 ng (gray dots) and 2 ng versus 10
ng (white dots). Gray dashed lines represent ideal normalized coverage per marker (1/153). B) Sequence read depth distribution per SNP considering all 1 ng
replicates of 2800 M control DNA (n = 25). The red dashed line represents 200 reads.
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the alternative allele; however, no significant difference in rates was
observed.
3.2.4. Sequencing baseline
The sequencing baseline was estimated by analyzing the number of
target reads at specific positions across the assay in a negative control
sample. Ten negative controls (H2O) were run across the Ion S5 runs of
the participating laboratories. In Supplementary Fig. S3C a more de-
tailed graphical representation of the mean distribution of reads across
all target sites of the BT assay is shown. As with estimation of the base
misincorporation rate, a distinction is made between reads with specific
(allelic) and non-specific nucleotide calls. Most observed reads showed
a specific allele and therefore, can be assumed as a result from cross
contamination between prepared samples and not the presence of ex-
traneous DNA. The mean number of reads obtained per target con-
sidering all negative controls was 34; however, one negative control
had a higher number of target reads, which possibly indicates con-
tamination during the automated library preparation process
(Supplementary Fig. S4). A thorough examination of the generated
profile and cross check with the other prepared samples led to the
identification of the sample that originated the NTC contamination to
be one of the GEDNAP samples prepared in the same library DL8 batch.
When excluding this negative control from analysis the mean number of
reads per target decreased to 29.
3.2.5. Allele read frequency balance
The SNP Genotyper output measures the MAF (major allele fre-
quency) parameter to help identify imbalanced markers. MAF-flagged
markers indicate that the major allele frequency falls outside of the
expected intervals for this parameter – set for this exercise to be 95–100
% for homozygotes and 35–65 % for heterozygotes (SNP Genotyper
default). To explore the overall assay performance in terms of allele
balance, particularly in heterozygotes, all 1 ng samples from 2800 M
and Coriell samples were considered for this analysis. The Coriell
samples provided additional genotype diversity due to their different
bio-geographical backgrounds. Supplementary Fig. S5A shows an
overview of this analysis, outlining MAF values for all control samples.
SNPs with outlying MAF values were categorized according to the
number of times values were outside the expected intervals
(Supplementary Fig. S5B). The majority of SNPs had only one or two
incidences (in 43 samples). However, SNPs rs1398461 and rs2605361
had 3–5 outlying MAF values and SNPs rs2789823 and rs7084970 had
more than five (highlighted in Supplementary Fig. S5A). Furthermore,
aiming to distinguish between the influence of the SNP on allele bal-
ance vs. the DNA sample in any one sequencing analysis; all 43 samples
used for this analysis were categorized based on the total number of
MAF flagged SNPs (Supplementary Fig. S5C). Most samples showed one
or two SNPs with a MAF flag, four samples had 3–5 MAF flagged SNPs
and four had more than 5 SNPs. The latter four samples comprised of
two 2800 M replicates and two NA07029 replicates.
Finally, only the SNPs rs2789823 and rs7084970 (both BGA mar-
kers) gave MAF values that consistently fell outside the expected in-
tervals (Supplementary Fig. S5A), indicating a balanced and consistent
sequencing performance for the assay as a whole. Nevertheless, special
care should be taken in routine genotype calling for rs2789823 and
rs7084970, and more detail on underperforming SNPs is given in sec-
tion 3.2.6.
3.2.6. Underperforming SNPs and IGV inspection
All samples were manually inspected using IGV to screen for mar-
kers with recurrent alignment issues, including polynucleotide tracts
and the possible presence of insertion/deletion polymorphisms (indels)
that could impair successful sequencing of the full amplicon. Seventeen
SNPs were identified to have possible alignment issues that could im-
pair sequencing of the full amplicon, including potential influence on
strand bias or SNPs showing reads with low mapping quality, which
could lead to higher misincorporation rates. Mapping quality represents
the probability of read misplacement and is normally reported using the
Phred scale [44]. For example, reads hitting a highly repetitive region
commonly have low mapping quality, as these have higher probability
of false alignments. All reproducibility replicates showed full genotype
concordance and no dropouts, but particular attention is needed when
considering low level/degraded DNA samples. The SNPs rs2789823 and
rs7084970 previously discussed in regard to allele read frequency im-
balance also had high total misincorporation rates (4.39 and 6.94 %,
respectively). Despite the latter being predominantly non-specific base
misincorporation (3.82 and 6.85 %, respectively), these high rates
could have led to increased occurrence of MAF flags. As previously
described, alignment visualization with IGV of rs7084970 showed a
poly-A tract immediately upstream of the SNP site, which is likely to
have caused the erroneous call of an “A” instead of a “T” base. Simi-
larly, SNP rs2789823 had a homopolymeric tract on the reverse strand,
likely to have impacted the base calling. SNPs rs2196051 and
rs2605361, showed strand bias towards the reverse strand (0.19 and
0.30, respectively). SNP rs2196051 showed several indels upstream of
the SNP site, which impaired the sequence of the forward strand, and
rs2605361 presented a poly-A tract upstream of the SNP site, causing
the same effect. SNPs rs2180052 and rs12498138 had strand bias to-
wards the forward strand. Examples of alignment visualizations are
outlined in Supplementary File S1. The full list of markers, alignment
comments and manual inspection advice is provided in Supplementary
Table S3.
3.3. Sensitivity
The performance of the BT A&A (Amp) assay at low DNA input
levels was assessed with a dilution series of a known control DNA
(Fig. 2). As expected, a reduction in read depth was observed with the
decreasing DNA input, except for a better performance of 0.1 ng re-
plicates (Fig. 2A). However, this can be explained as an artificial result
since 0.1 ng replicates were joined with lower input samples in the run
configuration, therefore, probably being overrepresented in the final
library pool produced by the Ion Chef. Automatic library preparation
with the Ion Chef produces a final library pool from an initial 8 sample
batch, which are combined after a bead normalization and regardless of
individual library quantity. Percentages of correct genotypes (CGT) per
mean dilution step are represented in black in Fig. 2B. Genotype in-
consistency, such as allele dropouts and dropins, incorrect genotype
calls (IGT), no detection (NN) and no reads are depicted in Fig. 2B. On
average, 0.1 ng input level replicates led to full SNP profiles and at 0.05
ng still 90.1 % of the genotypes were correct, while at 0.025 ng and
0.01 ng, only 79.3 % and 67.8 % of the full profile was successfully
genotyped, respectively. Such results agree with a previous study which
have also found the lower DNA input limit for full profiles around 0.1
ng [21], however it must be considered that sensitivity limits will vary
according to chip throughput, number of samples and assay size. At
0.05 ng and below, genotype discordances (dropouts, dropins and in-
correct calls) and no calls were observed. Among possible genotype
inconsistencies, allele dropouts occurred at the highest frequency in all
mean replicate dilutions. At 0.01 ng the mean amount of no calls (both
no reads and lack of sufficient reads for software detection) was higher
than the number of allele dropouts, however no SNP was identified with
a consistent dropout across the dilution series.
In SNP assays for individual identification and for BGA, a single
dropout and/or no call does not generally lead to strong consequences
for likelihood ratio calculations and ancestry estimation. In contrast,
the inference of EVCs can be much more sensitive to SNP loss and can
lead to erroneous predictions from biased likelihood values, depending
on the particular EVC-SNP missing [45]. Therefore, establishing a lower
DNA input limit for the BT A&A (Amp) tool is important and further
testing with data of consistently underperforming SNPs should be car-
ried out.
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An increased PCR cycle protocol (+ 5 cycles) resulted in higher
percentages of recovered genotypes for the low-input samples, 0.05 ng
(90.1 % improving to 96.5 %), 0.025 ng (79.3 %–88.9 %) and 0.01 ng
(67.8 %–74.3 %); corroborating the manufacturer’s suggestion for
protocol adjustment when typing low level or degraded DNA. Even
though there was an increase in successful genotype detection, there
was no increase in read depth distribution for the adjusted protocol
replicates (Fig. 2), which could also be the result of the artificial
overrepresentation of the 0.1 ng replicates in the sensitivity dilution
series. In fact, the increased PCR protocol samples were all prepared
within one batch (in duplicates, one batch in each laboratory) of library
DL8 chemistry and clearly showed a gradual decrease in read depth
distribution. On the contrary, the sensitivity series, which were pre-
pared in two batches, resulted in a more inconsistent read depth dis-
tribution between different inputs.
3.4. Concordance
Genotype concordance was assessed in two stages: i) between la-
boratories running the same set of samples (inter-laboratory con-
cordance) and ii) between the genotypes obtained with the BT A&A
(Amp) assay for six Coriell samples and the publicly available genotypes
in 1000 Genomes and SGDP. The inter-laboratory concordance study
compared genotypes from six samples run independently in three
VISAGE Consortium laboratories. Results showed full concordance for
all samples tested. There was a single discordant genotype between BT
A&A (Amp) sequencing results and genotype data stored in online da-
tabases in 609 genotypes: a concordance rate of 99.83 %. SNP
rs2789823 had a GG genotype for sample NA18498 using the BT A&A
(Amp) assay, which was an AG genotype in 1000 Genomes. An IGV
image of one replicate of NA18498 for the rs2789823 SNP position is
shown in Supplementary File S1, with no apparent alignment problems
observed at this site. Further investigation into the discordant position
was performed by comparing the BT A&A (Amp) genotype with the
data from the 1000 Genomes New York Genome Center high coverage
dataset, which was found fully concordant, reaching 100 % con-
cordance.
3.5. Mixtures
Mixture detection using binary markers is challenging, but has been
successfully achieved in previous forensic MPS studies
[20,21,25,41,43]. The basis for mixture detection with such markers is
the ratio of allele read frequencies observed when more than one
contributor is present. Allele read frequencies in single source samples
are expected to fall within the 90–100 % and 40–60 % ranges (with up
to 10 % baseline noise, although rarely this high, for the uncalled al-
lele). The allele read frequencies observed for single source and mixed
profiles are depicted in Fig. 3A and Supplementary Fig. S6. In routine
use, the SNP Genotyper output helps to identify a mixed profile by
flagging the major allele frequency parameter when outside the ranges
established for the assay (95–100 % and 35–65 % default ranges were
set for BT A&A). However, due to the SNP Genotyper limitation to call
binary SNPs, the extra information contained in the tri-allelic SNPs is
not automatically analyzed. Furthermore, the standard genotype calling
thresholds of 10 % minor allele read frequency also limits the calling of
mixture contributors present at very low levels.
An increased heterozygosity is also expected in mixed profile sam-
ples, a representation of the percentage of markers showing homo-
zygous and heterozygous genotypes for the single source samples and
the mixed replicates at different ratios is shown in Fig. 3B. The expected
mixed profile was also represented as an in silico combination of both
single source samples’ genotypes. The percentage of obtained hetero-
zygous SNPs found in replicates for 1:1 and 1:3 ratios match the ex-
pected in silico values, however 1:9 replicates showed smaller hetero-
zygosity percentages. This could be an artifact of the 10 % minor allele
Fig. 2. A) Mean replicate sequence read depth distribution per dilution step of the sensitivity study and per method (normal protocol and increased PCR cycles
protocol – PCR). B) Mean percentage of correct genotype (CGT) recovery and discordances (Dropout – allele dropout, Dropin – allele dropin, IGT – incorrect
genotype, NN – SNP Genotyper call failed and No Reads – locus dropout) per dilution step of the sensitivity study and by method (normal protocol and increased PCR
cycles protocol – PCR).
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read frequency threshold used by SNP Genotyper as the standard
threshold. Previous studies show decreasing this threshold helps to
identify minor contributors present at lower levels in mixed DNA
[21,43].
3.6. Challenging samples
Different types of challenging samples were used to assess the per-
formance of the assay both with samples obtained from different bio-
logical tissues and mimicking typical forensic casework DNA; as well as
samples with various degrees of degradation/fragmentation.
3.6.1. Casework type samples– GEDNAP
A batch of seven GEDNAP stains (Supplementary Table S4) were
sent to five VISAGE Consortium laboratories for extraction and quan-
tification according to their in-house validated protocols and prepared
following the BT A&A (Amp) analysis workflow. All genotypes obtained
per sample were compared (5,355 comparisons in total) and the ob-
served concordance rate was 99.8 %. In fact, only 11 discordant gen-
otypes were observed, and nine of these occurred with a single sample
(one replicate of 49S2). In general, this sample has produced low
quantification results from all laboratories (average of 2.45 ng/μL) and
particularly this replicate has shown the lowest quantification results
(0.07 ng/μL, Supplementary Table S4). Eight of the affected SNPs
showed low normalized read depths (< 0.0038, ideal nRD = 0.0065)
for the mean 1 ng reproducibility replicates. Two of the markers were
also listed as problematic SNPs (rs2196051 and rs12498138). The re-
maining two discordances occurred with replicates of one sample
(44S3) run in two different laboratories, one discordance derived from
a locus dropout and the second one called a TT genotype whereas the
remaining replicates showed a CT genotype, both in the same SNP
(rs5757362). Such results underline the robustness and versatility of
the BT A&A (Amp) assay in handling samples from different biological
tissues and analyzed with a range of differing extraction protocols.
3.6.2. Artificially degraded DNA samples
The read depth distribution of artificially degraded DNA samples
showed a gradual decrease with increasing sonication time, but this did
not affect genotyping success. Only the longest sonication replicates
(360 min) showed a visible decrease in correct genotype calls and oc-
currence of allele dropouts and dropins plus several no calls (Fig. 4A
and Supplementary Fig. S7). In fact, one of the 360 min replicates
showed such low read depth values that it was not possible to apply
SNP Genotyper, and this sample was excluded from further analysis.
The progressive degradation/fragmentation status of the sonicated
samples was verified by both real-time PCR quantification [46] and STR
typing (Supplementary Fig. S2), although the degradation did not affect
the VISAGE BT A&A (Amp) genotyping performance to the same de-
gree. One reason for this reduced effect is likely to be the assay design
considering shorter amplicon sizes for the SNP targets to achieve am-
plified fragments of reduced size, however the limited number of
samples analyzed per chip (16 samples) could be another explanation
for the genotyping success.
3.7. Inhibitor tolerance
The 2800 M control DNA replicates separately spiked with PCR
inhibitors showed a gradual decrease of read depth distribution with
increasing inhibitor concentration (Fig. 4B). However, the percentage
of correct genotype calls dropped dramatically above 4 × 10−4 μmol
(total input) of hematin, 200 ng of humic acid and 0.02 μmol of indigo
dye, clearly indicating the maximum PCR tolerance of these inhibitors
at such concentrations (Fig. 4C). It should be noted that all inhibitors
are described at total amount and not their concentration per reaction
volume. In fact, the DL8 automated library preparation solution uses 15
μL of input sample, but as all reagents (primers and enzyme) were
added automatically in the Ion Chef, calculation of the inhibitor con-
centration per reaction volume was not possible. All results were con-
cordant between replicates, further indicating the upper inhibitor tol-
erance limits of the assay. MPS inhibitor tolerance has not been
thoroughly studied by the forensic community, however, early results
showed another MPS library preparation method to be more sensitive to
inhibitors than routine STR profiling with capillary electrophoresis
methods [42]. Our results confirm this finding; e.g., the BT A&A (Amp)
assay is at least 18.7x and 15x more sensitive to the inhibiting effects of
hematin and humic acid respectively, as the commercial Promega
PowerPlex Fusion STR System (Promega, [47]). Such results increase
the necessity of further studying the effects of PCR inhibitors on MPS
assays and, more importantly, of improving current chemistry before
fully implementing them into forensic casework.
3.8. Species specificity
The results of primer specificity tests showed no evident amplifi-
cation of non-human DNA. Read depth distributions were very similar
to the negative control (Supplementary Fig. S8A), except for the
Fig. 3. A) Mean allele read frequency (minimum allele read frequency ≥ 0.2) per marker considering both single source samples and replicates of mixed ratios.
Dashed gray lines depict 10, 40, 60 and 90 % of allele read frequency. B) Percentage of observed homozygote and heterozygote genotypes per single source and
mixed sample. ‘Exp. Mixt.’ represents the expected percentage of homozygous and heterozygous genotypes when mixing in silico both single source genotypes.
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Bonobo sample, which had a wider range of read depth values.
Considering genotype calls, almost all targets failed for most samples,
with only a few successful genotype calls. Primate DNA samples, par-
ticularly the Bonobo but also others, showed higher percentages of
called genotypes (Supplementary Fig. S8B). Amplification with primate
DNA is not unusual and has been widely described in the literature
[47–49]; although the chances of finding primate DNA in forensic
casework are low. Even though the species specificity results were
compromised to some extent due to the underperforming positive
control sample in this batch (achieved only 77 % of the genotype calls,
similar to the Bonobo with 73 %), the higher percentage of genotype
calls and higher read depth from 2800 M control samples achieved in
the reproducibility set (both 16 sample sets per chip) indicate this to be
an anomalous result.
4. Conclusion
The BT A&A tool – a prototype MPS tool for simultaneous analysis of
eye, hair and skin color as well as continental biogeographic ancestry -
in particular its AmpliSeq version presented here - showed very good
overall performance in terms of sequence quality and coverage across
the whole range of component SNPs in the panel. The reproducibility
study demonstrated the BT A&A (Amp) assay to be sensitive to DNA
input for total coverage but not for the read depth distribution across
the SNPs of the assay, clearly indicating its robustness to different DNA
input levels. In agreement with previously reported AmpliSeq-based
methods applied on the Ion S5 sequencing instrument ([43], un-
published data), balanced strand representation in sequence number
was also seen for the BT A&A (Amp) assay. Low baseline noise and base
Fig. 4. A) Percentage of correct genotype (CGT) recovery and discordances (Allele dropout, Allele dropin, IGT – incorrect genotype and Locus dropout) per sample
used in the sonication time series and subjected to STR amplification (ESI) and capillary electrophoresis, and the BT A&A inference in duplicates. B) Duplicate mean
sequence read depth distribution for each series of inhibitor treatment (spiked 2800 M control DNA) – hematin, humic acid and indigo dye. C) Mean percentage of
correct genotype (CGT) recovery and discordances (Dropout – allele dropout, Dropin – allele dropin, IGT – incorrect genotype, NN – SNP Genotyper call failed and No
Reads – locus dropout) for each series of inhibitor treatment (spiked 2800 M control DNA) – hematin, humic acid and indigo dye.
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misincorporation rates were observed, which however did not influence
genotype calling and interpretation. Allele read frequency values in-
dicate a well-designed assay, with the exception of two SNPs, which
consistently presented major allele read frequency values outside the
optimum intervals (35–65 %). The panel’s ability to process low level or
degraded DNA typically found in forensic casework was shown by its
high sensitivity with full SNP profiles obtained down to 100 pg of input
DNA or 240 min of sonication. In addition, the increased PCR cycles
protocol, suggested by the manufacturer for challenging samples, gave
a slight increase in the recovery of correct genotypes. The assay
achieved 99.8 % genotyping concordance from casework-type samples,
demonstrating its success in analyzing DNA from different extraction
methods and tissue sources. However, the BT A&A (Amp) assay showed
poor inhibitor tolerance, particularly when compared with routine CE-
based STR typing kits. Such results agree with other forensic MPS stu-
dies [42] and underline the necessity for MPS suppliers to dedicate
resources for preparing forensically relevant MPS assay reagents that
contain components for the control of inhibitors; as are found in CE-
based STR reagent kits.
Mixture detection proved to be relatively straightforward when
observing imbalanced allele read frequencies and compiling the MAF
flags produced by SNP Genotyper – although the incapacity of the
software to call third alleles limits the efficiency of tri-allelic SNPs for
mixture genotyping and should be addressed in future versions of this
plug-in.
In conclusion, the presented AmpliSeq version of the VISAGE Basic
Tool for Appearance and Ancestry prediction provides a well-balanced,
specific and robust SNP sequencing assay suitable to be implemented
and applied in forensic DNA casework when information on continental
biogeographic ancestry as well as eye, hair, and skin color of an un-
known crime scene sample donor are suitable to aid police investiga-
tions, if legislation in the country of application allows [50]. Statistical
prediction tools to convert the genotype outcomes of the presented MPS
tool into probabilities of eye, hair, skin color categories and continental
BGA in a combined way are currently being developed by the VISAGE
Consortium. For the time being, existing separate tools are available for
use via the HIrisPlex (https://hirisplex.erasmusmc.nl/) and the Snipper
websites (http://mathgene.usc.es/snipper/), respectively. Future work
on the implementation of this panel into forensic routine laboratories
will bring a better insight into the performance of the BT A&A (Amp)
assay with real casework samples in the routine forensic DNA analysis
environment. Further developments on BT A&A versions that are not
based on AmpliSeq as well as expanding the VISAGE A&A tool towards
additional appearance traits and more detailed BGA are currently un-
derway.
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